Revenue nearly doubled but PBT fell 56% as costs outpaced growth

The effective tax rate climbed from 24.9% to 43.5%, which means NPAT fell roughly 10 percentage points further than PBT, so PBT is the cleaner read on operating performance. Group EBITDA was $1.6m (no comparable prior figure disclosed).

Operating cash flow was essentially unchanged at $1.1m (+3.9%) despite revenue doubling. The balance sheet expanded sharply: total assets more than doubled to $10.0m, gross borrowings of $2.3m now sit on the balance sheet against nil a year ago, and equity slipped 5.6% to $2.5m. Trade debtors more than tripled to $1.1m, lifting receivable days from 21.2 to 35.6. The release attributes $3.7m of revenue to recent acquisitions and $1.9m to organic growth (FY22 organic: $0.1m).

Capital raise adds balance-sheet context, with NZ$2m capital raised, but borrowings and gearing are the direct leverage evidence.

PBT declined 56.2% on a 94.4% revenue uplift, indicating the cost base expanded faster than the top line. This is the central tension in the result: management has built scale, but FY23 absorbed direct and indirect integration and consolidation costs in the first half that the second half did not fully recover. Until margin recovery is demonstrated in a clean period, the operating economics of the larger group remain unproven.

Tax distortion widened the headline decline. The effective tax rate moved from 24.9% to 43.5%, a roughly 18.6pp step-up. No driver is disclosed in the supplied material, so NPAT understates the underlying operating result and full reconciliation is outstanding. Investors should weight PBT over NPAT when judging FY23 performance.

Working capital absorbed cash that revenue would otherwise have produced. Operating cash flow rose just 3.9% while revenue rose 94.4%, because receivable days lengthened from 21.2 to 35.6 and operating working capital expanded by roughly $0.8m. This matters because it raises the cash cost of growth and, if it persists, will constrain dividend and debt-service capacity at the new larger scale.

The half-year split is therefore the only available shape reference: 1H23 contained roughly 39.9% of full-year revenue and 44.6% of full-year EBITDA, but 74% of reported NPAT, so 2H reported NPAT was materially weaker than 1H ($0.1m vs $0.3m). Management points to underlying second-half improvement and a $150k annualised cost reduction; that framing is not visible in reported NPAT. The release does not provide enough to judge whether FY24 will inherit a recovered or still-compressed margin from the second half, which is the key open shape question.

Less durable signals dominate the read. Operating cash flow barely moved despite revenue doubling, because $0.8m of incremental working capital tied up the growth. The dividend at 122.4% of NPAT exceeds reported earnings cover, leaving FCF, not earnings, as the funding source for distributions. ROE fell from 43.5% to 17.2%, partly reflecting a larger asset base now carrying $2.3m of debt against $2.5m of equity. The combination of higher leverage, longer receivable days, and a tax line that has not been reconciled in the supplied disclosures means the FY23 print should not yet be treated as a clean baseline for forward earnings power.

This briefing cannot assess management's specific cost-reduction initiatives, segment-level margin trajectories, or FY24 trading momentum because the supplied material contains no forward financial guidance or post-period trading commentary.